Australia's Respiri logs best day in 4 months on deal with U.S.-based mTelehealth

Vitasora Health

23/12/2021 04:01

** Shares of Respiri Ltd  RSH.AX  jump as much as 14% to
A$0.065, biggest intraday pct gain since Aug. 13
    ** Medical devices and apps maker says it signed 5-year
distribution and marketing deal with mTelehealth in U.S.
 urn:newsml:reuters.com:*:nFWN2T70UY
    ** As part of deal, mTelehealth has placed orders for
digital wheezing monitoring devices worth $150,000 for delivery
in January 2022
    ** "This Agreement is material, as the Company currently has
no US sales for wheezo" - RSH
    ** mTelehealth forecasts minimum sales of $1 mln over the
life of deal
    ** RSH hits highest since Nov. 22
    ** Company's shares down 56.2% this year, as of last close

 (Reporting by Archishma Iyer)
 ((Archishma.Iyer@thomsonreuters.com))